Coherent Expands Medical Photonics Portfolio with AxioView Imaging Fiber Assemblies
Event summary
- Coherent launched AxioView™ imaging fiber assemblies on January 16, 2026 for OCT and NIRS applications.
- Product targets cardiovascular, neurovascular, and gastrointestinal catheter-based imaging systems.
- AxioView features ISO 13485-certified production for regulatory compliance and vertically integrated manufacturing.
- Product debuts at Photonics West 2026 in San Francisco.
The big picture
Coherent's AxioView launch targets the expanding market for image-guided, minimally invasive procedures driven by aging populations. The product leverages Coherent's vertically integrated manufacturing and regulatory expertise to position itself as a key supplier in the medical photonics space. This move aligns with broader industry trends toward higher-resolution imaging solutions and streamlined development timelines for medical device OEMs.
What we're watching
- Market Adoption
- How quickly medical OEMs integrate AxioView into their catheter platforms.
- Regulatory Compliance
- Whether ISO 13485 certification accelerates time-to-market for customers.
- Competitive Positioning
- The pace at which Coherent can differentiate itself in the growing medical photonics sector.
Related topics